TRUNCATE-TB trial sponsors

The National University Health System (NUHS) is an integrated academic health system in Singapore that served as the primary sponsor for the landmark TRUNCATE-TB clinical trial. The trial investigated a novel strategy for treating drug-susceptible tuberculosis by shortening the standard six-month treatment regimen to two months using intensified drug combinations. NUHS collaborates extensively with the National University of Singapore and international partners like University College London to advance clinical research in infectious diseases. Their work on TRUNCATE-TB has provided high-quality evidence for stratified medicine approaches in global health.